Compare GDRX & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDRX | IART |
|---|---|---|
| Founded | 2011 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2020 | 1996 |
| Metric | GDRX | IART |
|---|---|---|
| Price | $3.27 | $16.09 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 12 |
| Target Price | $4.03 | ★ $19.56 |
| AVG Volume (30 Days) | ★ 767.6K | 725.5K |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.00 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $796,853,000.00 | N/A |
| Revenue This Year | $0.18 | $2.40 |
| Revenue Next Year | $5.06 | $3.17 |
| P/E Ratio | $109.00 | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $1.77 | $8.70 |
| 52 Week High | $5.61 | $20.49 |
| Indicator | GDRX | IART |
|---|---|---|
| Relative Strength Index (RSI) | 45.50 | 50.17 |
| Support Level | $3.29 | $16.04 |
| Resistance Level | $3.58 | $16.38 |
| Average True Range (ATR) | 0.10 | 0.62 |
| MACD | -0.02 | 0.14 |
| Stochastic Oscillator | 24.29 | 74.87 |
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.